GRDN

GUARDIAN PHARMACY SVCS INC

GRDN·40145W101·US·Common Stock·Healthcare - Medical Care Facilities-Activist

GRDN (GUARDIAN PHARMACY SVCS INC) is held by 108 institutional investors as of Q2 2026. Largest holders: FMR LLC ($135.7M), WELLINGTON MANAGEMENT GROUP LLP ($72.4M), BlackRock, Inc. ($66M). Net institutional sentiment: Mixed.

108
Holders
(7 Elite)
$909.6M
Total Value
58% (107)
Consensus
62 buying - 45 selling
13F: Insider & Congress: Updated regularly
GRDN

Smart Money Verdict

View all
Loading verdict
Held by 108 funds
7 elite

Who's Trading

Source dates: Price Aug 18, 2026 · Insiders May 7, 2026 · Activists May 6, 2026 · Congress none

ActivistFMR LLCFMR LLC6.5%May 6, 2026
InsiderCDCOSLER STEVEN DVest 4K shMay 5, 2026
InsiderPSPatchett Mary SueVest 4K shMay 5, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
3.2M(+37.4%)$135.7M0.0%+5.84%
40
Decreased
1.7M(-2.0%)$72.4M0.0%+51.80%
0
Decreased
1.6M(-10.3%)$66M0.0%+60.69%
0
Increased
1.4M(+12.6%)$57.8M0.0%+9.64%
33
Increased
1.3M$54.7M0.2%+68.86%
35
Decreased
983,868(-3.3%)$40.8M0.0%+51.88%
0
Increased
966,206(+1.4%)$40.5M0.0%+90.98%
29
Decreased
869,836(-6.6%)$36.4M0.0%+21.67%
0
Increased
646,695(+15.7%)$27.1M0.0%+44.09%
33
Decreased
626,664(-23.8%)$26.2M0.0%+14.24%
0
Increased
590,114(+15.9%)$24.7M0.0%+42.14%
33
Decreased
524,013(-58.4%)$21.9M0.0%+85.99%
0
Increased
516,094(+147.4%)$21.6M0.0%+0.22%
46
Decreased
510,161(-13.4%)$21.4M0.1%+76.60%
0
Increased
461,307(+392.4%)$19.3M0.0%-4.97%
46
Decreased
345,229(-7.9%)$14.5M0.1%+79.05%
0
Increased
312,004(+166.7%)$13.1M0.0%+7.71%
45
Increased
307,879(+17.9%)$12.9M0.0%+8.65%
33
Increased
301,400(+200x)$12.6M0.0%-8.40%
45
Unchanged
275,000$11.5M0.0%+12.46%
0

Showing 1-20 of 114

1 / 6
GRDNGRDNGUARDIAN PHARMACY SVCS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used